The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
Jeff Galvin is the CEO and Founder of American Gene Technologies™ (AGT). He earned his BA degree in Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups.
Top 10 Biotech News Stories from 2019 from the BioHealth Capital Region on biobuzz.io
Here’s Why the First Cure for HIV Could Emerge from Maryland These Five Life Science Organizations are Striving to Cure HIV November 5, 2019 For those that lived through the [….]